Furthermore, we performed a meta-analysis of HPV prevalence in patients with NSCLC and EGFR mutations compared with patients with NSCLC and without EGFR mutations from seven populations worldwide (Supplemental Material(Supplementary material)). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.